Pharmetheus offers consulting services focused on the application of quantitative approaches to support drug research, development and life-cycle decisions.
Latest news from Pharmetheus.
What is the immunogenic profile of a drug and what to do about it? At Pharmetheus, we have, together with the whole team, reviewed with interest the new draft FDA guidance.
On the QSP side, we are progressing with our contributions to the subcutaneous delivery platform, upon which Erik Sjögren will present at PAGE: A platform for mechanistic modelling of subcutaneous administration with the effect of immunogenicity within the Open Systems Pharmacology framework
When it comes to PKPD models, we are following the collaborative advances in Hidden Markov Modeling, with contributions by Elodie Plan:
Our services include quantitative analyses by scientists with extensive therapeutic area experience industry, academic and regularly settings.
If you are interested in our services, please fill out the form below.
Our way of working, with traceability and accountability from data programming to report delivery, is well adapted to, and highly compatible with, current regulatory requirements.
Pharmetheus offers consulting services focused on the application of quantitative approaches to support drug development decisions..